Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 953891
                    [Title] => Lilly stops mid-stage Alzheimer's drug study
                    [Summary] => 
Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.

                    [DatePublished] => 2013-06-14 08:00:48
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => http://img10.imageshack.us/img10/3674/8amf.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 918810
                    [Title] => Drugmakers, Interpol ramp up fight against fakes
                    [Summary] => 
More than two dozen of the world's largest pharmaceutical companies have agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs, the international police agency said Tuesday.

                    [DatePublished] => 2013-03-12 14:08:54
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

ELI LILLY AND CO

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 953891
                    [Title] => Lilly stops mid-stage Alzheimer's drug study
                    [Summary] => 
Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.

                    [DatePublished] => 2013-06-14 08:00:48
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => http://img10.imageshack.us/img10/3674/8amf.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 918810
                    [Title] => Drugmakers, Interpol ramp up fight against fakes
                    [Summary] => 
More than two dozen of the world's largest pharmaceutical companies have agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs, the international police agency said Tuesday.

                    [DatePublished] => 2013-03-12 14:08:54
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

Lilly stops mid-stage Alzheimer's drug study

June 14, 2013 - 8:00am

Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because...

World

Drugmakers, Interpol ramp up fight against fakes

March 12, 2013 - 2:08pm

More than two dozen of the world's largest pharmaceutical companies have agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs, the international police agency said...

Health And Family